PGR and ductal breast carcinoma in situ: Previous studies have attempted to evaluate and interpret the relationship between mammographic calcifications and tumor histology or the expression of selected biological markers, such as estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), using immunohistochemistry and have shown that breast cancers with mammographic calcifications are more frequently associated with invasive cancer with extensive ductal carcinoma in situ (DCIS) or HER2-positive breast cancer15–20.